[go: up one dir, main page]

NO1998007I1 - Ranitidin-vismutcitrat - Google Patents

Ranitidin-vismutcitrat

Info

Publication number
NO1998007I1
NO1998007I1 NO1998007C NO1998007C NO1998007I1 NO 1998007 I1 NO1998007 I1 NO 1998007I1 NO 1998007 C NO1998007 C NO 1998007C NO 1998007 C NO1998007 C NO 1998007C NO 1998007 I1 NO1998007 I1 NO 1998007I1
Authority
NO
Norway
Prior art keywords
bismuth citrate
ranitidine bismuth
ranitidine
citrate
bismuth
Prior art date
Application number
NO1998007C
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888817098A external-priority patent/GB8817098D0/en
Priority claimed from GB898904686A external-priority patent/GB8904686D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO1998007I1 publication Critical patent/NO1998007I1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
NO1998007C 1988-07-18 1998-02-05 Ranitidin-vismutcitrat NO1998007I1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888817098A GB8817098D0 (en) 1988-07-18 1988-07-18 Chemical compounds
GB898904686A GB8904686D0 (en) 1989-03-01 1989-03-01 Chemical compounds

Publications (1)

Publication Number Publication Date
NO1998007I1 true NO1998007I1 (no) 1998-02-05

Family

ID=26294175

Family Applications (2)

Application Number Title Priority Date Filing Date
NO892936A NO176319C (no) 1988-07-18 1989-07-17 Analogifremgangsmåte for fremstilling av terapeutisk aktive furanderivater
NO1998007C NO1998007I1 (no) 1988-07-18 1998-02-05 Ranitidin-vismutcitrat

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO892936A NO176319C (no) 1988-07-18 1989-07-17 Analogifremgangsmåte for fremstilling av terapeutisk aktive furanderivater

Country Status (35)

Country Link
US (1) US5008256A (no)
JP (1) JP2523185B2 (no)
KR (1) KR0122598B1 (no)
CN (1) CN1022626C (no)
AT (1) AT398200B (no)
AU (1) AU632052B2 (no)
BE (1) BE1003254A5 (no)
CA (1) CA1332610C (no)
CH (1) CH679582A5 (no)
CY (1) CY1650A (no)
DE (1) DE3923638C2 (no)
DK (1) DK168381B1 (no)
EG (1) EG19368A (no)
ES (1) ES2014175A6 (no)
FI (1) FI90538C (no)
FR (1) FR2634122B1 (no)
GB (1) GB2220937B (no)
GR (1) GR1000431B (no)
HK (1) HK61392A (no)
HU (2) HU206104B (no)
IE (1) IE61076B1 (no)
IL (1) IL91005A (no)
IT (1) IT1231481B (no)
LU (2) LU88722I2 (no)
MX (1) MX174145B (no)
MY (1) MY104055A (no)
NL (2) NL192604C (no)
NO (2) NO176319C (no)
NZ (1) NZ229958A (no)
PL (1) PL162391B1 (no)
PT (1) PT91188B (no)
SE (1) SE468715B (no)
SG (1) SG51992G (no)
YU (1) YU47021B (no)
ZW (1) ZW8689A1 (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
ATE81011T1 (de) * 1987-03-09 1992-10-15 Procter & Gamble Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
AU641903B2 (en) * 1988-10-26 1993-10-07 Glaxo Group Limited Carboxylic acid derivatives
GB9004328D0 (en) * 1990-02-27 1990-04-25 Glaxo Group Ltd Chemical compounds
GB9009240D0 (en) * 1990-04-25 1990-06-20 Glaxo Group Ltd Chemical compounds
GB9009437D0 (en) * 1990-04-26 1990-06-20 Glaxo Group Ltd Chemical compounds
JP2688541B2 (ja) * 1990-07-20 1997-12-10 テイロツツ・フアーマ・アクチエンゲゼルシヤフト 消化管治療のための製品及び方法
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
DK0550083T3 (da) * 1991-12-06 1999-10-11 Glaxo Group Ltd Lægemidler til behandling af inflammatoriske tilstande eller til analgesi og indeholdende et NSAID og ranitidinbismuthcitra
EP0666855B1 (en) * 1992-10-27 1996-09-18 Janssen Pharmaceutica N.V. 4-quinolinyl derivatives with anti-helicobacter activity
WO1996019232A1 (en) * 1994-12-19 1996-06-27 Lauteral Limited Combinations of ranitidine hydrochloride-form 1 and bismuth compounds
CA2211873A1 (en) * 1995-01-26 1996-08-01 Michael Droege Bismuth compounds
GB9501560D0 (en) 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
RU2131264C1 (ru) * 1996-06-04 1999-06-10 Московское производственное химико-фармацевтическое объединение им.Н.А.Семашко Противоязвенное средство в виде таблеток и способ его получения
EP1035192A1 (de) * 1999-01-26 2000-09-13 Stefan Graichen Additiv für einen Kühlschmierstoff
CN1102585C (zh) * 1999-04-28 2003-03-05 常州兰陵制药有限公司 雷尼替丁枸橼酸铋盐的制备方法
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
CN100402514C (zh) * 2006-08-01 2008-07-16 丽珠医药集团股份有限公司 一种制备枸橼酸铋雷尼替丁的方法
AU2007216671B2 (en) * 2007-07-09 2009-07-16 Cypress Pharmaceutical, Inc. Pleasant-tasting ranitidine formulation
CN102408398B (zh) * 2011-09-20 2012-12-05 江苏汉斯通药业有限公司 枸橼酸铋雷尼替丁的制备方法
US9731999B2 (en) 2011-09-23 2017-08-15 Iqbal Gill Chemical admixtures for hydraulic cements
ES2426539B1 (es) * 2012-04-18 2014-09-09 Dr Healthcare España, S. L. Uso de la diaminooxidasa para el tratamiento o la prevención del trastorno por deficit de atencion con hiperactividad (adhd)
CN103896888B (zh) * 2014-03-28 2015-11-18 常州兰陵制药有限公司 枸橼酸铋雷尼替丁的制备方法
EP2929884A1 (en) 2014-04-11 2015-10-14 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of dabigatran and h2-receptor antagonists
EP2942058A1 (en) 2014-05-09 2015-11-11 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of rivaroxaban and H2-receptor antagonists
CN107382921B (zh) * 2017-07-28 2025-04-18 常州兰陵制药有限公司 制备枸橼酸铋雷尼替丁的方法
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
FR2531706A1 (fr) * 1982-08-13 1984-02-17 Sanofi Sa Benzamides, leurs sels, procede pour leur preparation et compositions pharmaceutiques les renfermant
BE905235A (fr) * 1986-08-05 1986-12-01 Hasunor Ag Ascorbates antagonistes des recepteurs h2 et leur procede de preparation.
IT1215325B (it) * 1987-01-07 1990-02-08 Barisintex Sa Composti antagonisti di recettori -h2 e procedimento per la loro preparazione.
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
ATE81011T1 (de) * 1987-03-09 1992-10-15 Procter & Gamble Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
DE3710462A1 (de) * 1987-03-30 1988-10-13 Heumann Pharma Gmbh & Co Pharmazeutische zubereitung zur behandlung von erkrankungen des magen-darm-traktes
GB9004328D0 (en) * 1990-02-27 1990-04-25 Glaxo Group Ltd Chemical compounds
GB9009437D0 (en) * 1990-04-26 1990-06-20 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
IL91005A (en) 1994-10-07
HU211173A9 (en) 1995-11-28
IE61076B1 (en) 1994-09-21
GR890100454A (en) 1990-06-27
CN1039419A (zh) 1990-02-07
KR910002826A (ko) 1991-02-26
DK351789A (da) 1990-01-19
US5008256A (en) 1991-04-16
EG19368A (en) 1995-02-28
FI893448A0 (fi) 1989-07-17
ATA172889A (de) 1994-02-15
MX174145B (es) 1994-04-25
DE3923638A1 (de) 1990-03-01
ES2014175A6 (es) 1990-06-16
NZ229958A (en) 1991-09-25
MX16829A (es) 1993-10-01
CH679582A5 (no) 1992-03-13
SE8902550D0 (sv) 1989-07-17
MY104055A (en) 1993-10-30
AT398200B (de) 1994-10-25
FI90538B (fi) 1993-11-15
FI90538C (fi) 1994-02-25
DE3923638C2 (de) 1995-11-23
FR2634122A1 (fr) 1990-01-19
PL162391B1 (pl) 1993-10-30
CY1650A (en) 1992-12-11
CN1022626C (zh) 1993-11-03
BE1003254A5 (fr) 1992-02-11
SE8902550L (sv) 1990-01-19
NO892936D0 (no) 1989-07-17
NL970046I1 (nl) 1998-03-02
IT1231481B (it) 1991-12-07
GB8916288D0 (en) 1989-08-31
SG51992G (en) 1992-07-24
NL192604C (nl) 1997-11-04
GR1000431B (el) 1992-07-30
IL91005A0 (en) 1990-02-09
JP2523185B2 (ja) 1996-08-07
LU87557A1 (fr) 1990-07-24
AU632052B2 (en) 1992-12-17
NL970046I2 (nl) 1998-04-01
KR0122598B1 (ko) 1997-11-13
GB2220937B (en) 1991-11-27
GB2220937A (en) 1990-01-24
YU47021B (sh) 1994-11-15
NO892936L (no) 1990-01-19
PT91188A (pt) 1990-02-08
FI893448L (fi) 1990-01-19
YU142789A (en) 1991-04-30
HK61392A (en) 1992-08-21
NO176319C (no) 1995-03-15
ZW8689A1 (en) 1990-02-21
IT8948196A0 (it) 1989-07-17
PT91188B (pt) 1995-03-01
NO176319B (no) 1994-12-05
HU206104B (en) 1992-08-28
LU88722I2 (fr) 1996-08-23
NL192604B (nl) 1997-07-01
HUT52082A (en) 1990-06-28
FR2634122B1 (fr) 1993-11-19
CA1332610C (en) 1994-10-18
JPH02117684A (ja) 1990-05-02
SE468715B (sv) 1993-03-08
DK351789D0 (da) 1989-07-17
DK168381B1 (da) 1994-03-21
AU3817889A (en) 1990-01-18
IE892309L (en) 1990-01-18
NL8901840A (nl) 1990-02-16

Similar Documents

Publication Publication Date Title
NO1998007I1 (no) Ranitidin-vismutcitrat
DK237884A (da) Ranitidinpraeparater
DE59007693D1 (de) Schlafmaske.
DE68914143D1 (de) Rumen-stabile kügelchen.
DK540389A (da) Immunstimulerende praeparat
NO890505L (no) Vandig blekepreparat.
DK382787A (da) Mikrobicid
DE3771563D1 (de) Ballenzerreisser.
DK109789A (da) Biocidt virksomme forbindelser
DE68909560D1 (de) Trennbarer reissverschluss.
FI863538A7 (fi) Alapatja.
DK296589D0 (da) Mikrobicid
DE68910003D1 (de) Ballenpresse.
BG78365A (bg) Инсектицидно средство
FI894714L (fi) Fluorsubstituerade benzenderivat.
DK13889D0 (da) Insecticid
BR8903483A (pt) Construcao de colchao
IT8948537A0 (it) Perfezionata composizione pesticida
FI862900A7 (fi) Muotoiltu vuodevaate.
DK16489A (da) Immunstimulerende praeparat.
DK551588A (da) Parasitmiddel
DK677087D0 (da) Mikrobicid
DK606288D0 (da) Praeparat
DK295787A (da) Fungicider
IT1229015B (it) Tomografia.